COGT – cogent biosciences, inc. (US:NASDAQ)
Stock Stats
News
Cogent Biosciences, Inc. (NASDAQ: COGT) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference [Yahoo! Finance]
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference
Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target lowered by analysts at Robert W. Baird from $10.00 to $8.00. They now have a "neutral" rating on the stock.
Form S-8 Cogent Biosciences, Inc.
Form 10-K Cogent Biosciences, Inc. For: Dec 31
Form 8-K Cogent Biosciences, Inc. For: Feb 25
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Form SCHEDULE 13G Cogent Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.